Vericel Corp Ord (VCEL)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 68.64% | 67.66% | 67.31% | 66.66% | 66.80% | 66.29% | 66.00% | 67.53% | 67.88% | 68.68% | 69.94% | 68.49% | 67.83% | 67.08% | 66.98% | 68.34% | 68.12% | 67.56% | 66.17% | 64.99% |
| Operating profit margin | -3.27% | -7.08% | -8.33% | -10.61% | -10.38% | -11.93% | -11.07% | -7.50% | -5.03% | 0.19% | 5.79% | 3.14% | 1.91% | -0.60% | -0.97% | -10.57% | -9.55% | -13.18% | -18.57% | -3.11% |
| Pretax margin | -1.20% | -5.31% | -6.98% | -9.68% | -9.72% | -11.55% | -10.81% | -7.31% | -4.85% | 0.40% | 6.04% | 3.49% | 2.45% | 0.12% | -0.00% | -9.39% | -8.20% | -12.68% | -18.14% | -3.51% |
| Net profit margin | -1.61% | -5.53% | -7.39% | -10.10% | -10.16% | -11.36% | -10.60% | -7.15% | -4.78% | 0.14% | 5.78% | 3.24% | 2.31% | 0.12% | -0.00% | -9.39% | -8.20% | -12.68% | -18.14% | -3.51% |
Vericel Corp's profitability ratios have shown fluctuations in recent quarters. The gross profit margin has been relatively stable, ranging from 66.00% to 68.64% over the past eight quarters, indicating the company's ability to efficiently generate profit from its operations.
However, the operating profit margin, pretax margin, and net profit margin have exhibited negative trends, with Q4 2023 recording the lowest values at -3.27%, -1.20%, and -1.61%, respectively. This suggests that the company has been facing challenges in controlling its operating expenses and other costs, resulting in lower profitability levels.
The declining trend in profitability margins raises concerns about Vericel Corp's operational efficiency and overall financial performance. It may be imperative for the company to evaluate its cost structure, revenue generation strategies, and overall business operations to enhance profitability and ensure sustainable growth in the competitive healthcare sector.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -1.83% | -4.12% | -4.78% | -6.78% | -6.25% | -7.66% | -7.02% | -4.92% | -3.22% | 0.13% | 3.95% | 1.96% | 1.15% | -0.45% | -0.77% | -8.63% | -7.34% | -10.52% | -15.02% | -2.09% |
| Return on assets (ROA) | -0.90% | -3.22% | -4.24% | -6.45% | -6.12% | -7.30% | -6.72% | -4.69% | -3.07% | 0.10% | 3.95% | 2.02% | 1.39% | 0.09% | -0.00% | -7.67% | -6.31% | -10.12% | -14.67% | -2.35% |
| Return on total capital | -1.63% | -5.42% | -6.90% | -8.62% | -8.12% | -10.27% | -9.57% | -6.67% | -4.45% | 0.39% | 6.06% | 3.29% | 2.27% | -0.12% | -0.62% | -11.40% | -10.13% | -14.91% | -21.34% | -2.86% |
| Return on equity (ROE) | -1.41% | -5.01% | -6.62% | -8.82% | -8.69% | -10.18% | -9.41% | -6.54% | -4.38% | 0.14% | 5.80% | 3.05% | 2.13% | 0.13% | -0.00% | -10.44% | -8.70% | -14.36% | -20.85% | -3.22% |
Vericel Corp's profitability ratios have shown a mixed performance over the past eight quarters. In terms of Operating ROA, the company has been experiencing negative returns ranging from -1.83% to -6.78%. This indicates that the company's core operations are not generating sufficient profits relative to its total assets.
Looking at the overall ROA, Vericel Corp's performance has also been negative, varying from -0.90% to -6.46%. This metric reflects the company's ability to generate profit from its total assets, including both operational and non-operational assets.
The return on total capital has been consistently negative for Vericel Corp, with figures ranging from -2.86% to -9.26% over the observed period. This ratio evaluates the company's ability to generate returns for both equity and debt investors.
Furthermore, the return on equity (ROE) for Vericel Corp has also shown a negative trend, varying between -1.41% and -8.82%. ROE indicates how effectively the company is utilizing shareholders' equity to generate profits.
Overall, Vericel Corp's profitability ratios suggest that the company has been facing challenges in generating profits from its assets, capital, and equity over the past eight quarters. Further analysis of the company's financial and operational strategies may be necessary to address these profitability challenges.